bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
Advancing in silico drug design with Bayesian refinement of AlphaFold models
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Artificial intelligence-driven drug discovery: a deep learning paradigm shift in pharmaceutical research and development.#1080566
- Artificial Intelligence in Pharmaceutical Care: Transforming Drug Discovery, Development, and Patient-care Delivery.#421025
- From Antibiotics to Cancer Therapeutics: In Silico Design of Novel Ribosomal Assembly Inhibitors / Theresa Clare Noonan#1119823
- AI and network biology for rational polypharmacology in signaling drug design: a review.#297263
- In silico preformulation studies, including drug-excipient interaction or compatibility studies, using an AI-based computational model and expert system#244673
Record · ID 259231
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive